[Federal Register: April 14, 2004 (Volume 69, Number 72)]
[Notices]               
[Page 19872]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr14ap04-94]                         


[[Page 19872]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 2003N-0506]

 
Agency Information Collection Activities; Announcement of Office 
of Management and Budget Approval; Experimental Study of Possible 
Footnotes and Cuing Schemes to Help Consumers Interpret Quantitative 
Trans Fat Disclosure on the Nutrition Facts Panel

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that a 
collection of information entitled ``Experimental Study of Possible 
Footnotes and Cuing Schemes to Help Consumers Interpret Quantitative 
Trans Fat Disclosure on the Nutrition Facts Panel'' has been approved 
by the Office of Management and Budget (OMB) under the Paperwork 
Reduction Act of 1995.

FOR FURTHER INFORMATION CONTACT:  Peggy Robbins, Office of Management 
Programs (HFA-250), Food and Drug Administration, 5600 Fishers Lane, 
Rockville, MD 20857, 301-827-1223.

SUPPLEMENTARY INFORMATION: In the Federal Register of November 10, 2003 
(68 FR 63901), the agency announced that the proposed information 
collection had been submitted to OMB for review and clearance under 44 
U.S.C. 3507. An agency may not conduct or sponsor, and a person is not 
required to respond to, a collection of information unless it displays 
a currently valid OMB control number. OMB has now approved the 
information collection and has assigned OMB control number 0910-0532. 
The approval expires on September 30, 2004. A copy of the supporting 
statement for this information collection is available on the Internet 
at http://frwebgate.access.gpo.gov/cgi-bin/leaving.cgi?from=leavingFR.html&log=linklog&to=http://www.fda.gov/ohrms/dockets.


    Dated: April 2, 2004.
Jeffrey Shuren,
Assistant Commissioner for Policy.
[FR Doc. 04-8388 Filed 4-13-04; 8:45 am]

BILLING CODE 4160-01-S